Toronto, Canada – BTNX Inc. has launched a series of Rapid Response® advanced FDA approved point of care in-vitro diagnostic drugs of abuse tests, which are used for home, professional and corporation point of care drugs of abuse testing.
The drug tests can easily detect any of Amphetamine, Barbiturate, Benzodiazepine, Buprenorphine, Cocaine, Ecstasy, EDDP (Methadone Metabolite), Heroin, Marijuana, Methadone, Methamphetamine, Morphine, Opiate, Oxycodone, Phencyclidine, Propoxyphene, Tricyclic Antidepressant. Or any combinations range from 1 test panel to 12 test panels.
Rapid Response ® point of care drugs of abuse test series includes urine drug test cups, urine drug test panels, urine drug test strips, urine drug test cassettes, saliva drug tests and lab hair drug tests.
Rapid Response® branded point of care drugs of abuse tests are trusted by professionals in laboratories, physicians’ offices, hospitals and clinics worldwide for their diagnostic testing requirements.